Showing results (1-10 of 167) with videos related to
Sort By:
Pageof 17
Clinical Chemistry|April 1, 1991
Neuron-specific enolase concentrations in serum in benign liver diseasesJ Collazos, J Genollá, A RuibalScandinavian Journal of Clinical and Laboratory Investigation|October 1, 1993
A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disordersJ Collazos, J Genollá, A RuibalDigestion|January 1, 1992
A clinical and laboratory evaluation of the behavior of tissue polypeptide antigen in liver cirrhosisJ Collazos, J Genollá, A RuibalThe International Journal of Biological Markers|July 1, 1991
CA 15.3 in nonmalignant liver diseasesJ Collazos, J Genollá, A RuibalThe Clinical Investigator|May 1, 1993
Study of serum procollagen type III peptide in patients with hepatic cirrhosis from a clinical point of viewF Díaz, J Collazos, J GenolláJournal of Clinical Gastroenterology|March 1, 1994
Serum laminin levels offer only a little additional information in liver diseaseF Díaz, J Collazos, J GenolláGut|July 1, 1993
Serum concentrations of laminin in cirrhosis of the liverJ Collazos, F Díaz, J GenolláAmerican Journal of Respiratory and Critical Care Medicine|July 1, 1994
Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseasesJ Collazos, C Esteban, A Fernández, et al.Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1992
CA 125 serum levels in patients with non-neoplastic liver diseases. A clinical and laboratory studyJ Collazos, J Genolla, A RuibalClinical Nuclear Medicine|January 1, 1993
Study of the tumor marker carbohydrate antigen 50 in liver cirrhosis. Pathogenetic considerationsJ Collazos, J Genolla, A RuibalPageof 17